PTEN was barely detectable in 1205Lu cells, despite its heterozygous loss of PTEN. Expression of p-ERK (T202/Y204) was decreased in parental cells with the combined BRAF and MEK inhibition, but was unchanged or only slightly decreased in CR melanoma cell lines after the same treatment. The gene discussed is PTEN; the disease is melanoma.